Free Trial

KDA Group (CVE:KDA) Stock Price Up 26.3% - Still a Buy?

KDA Group logo with Medical background

KDA Group Inc. (CVE:KDA - Get Free Report)'s stock price rose 26.3% during mid-day trading on Thursday . The stock traded as high as C$0.36 and last traded at C$0.36. Approximately 557,858 shares changed hands during mid-day trading, an increase of 511% from the average daily volume of 91,344 shares. The stock had previously closed at C$0.29.

KDA Group Price Performance

The stock has a market cap of C$63.14 million, a P/E ratio of -7.50 and a beta of 1.24. The firm has a 50-day moving average price of C$0.26 and a 200-day moving average price of C$0.27. The company has a debt-to-equity ratio of 7.36, a quick ratio of 0.35 and a current ratio of 2.10.

About KDA Group

(Get Free Report)

KDA Group Inc, together with its subsidiaries, provides solutions and services to pharmacies and pharmaceutical companies in Canada. The company operates through three segments: Pharmacy Services, Pharmaceutical Solutions, and Technology. It provides pharmacy staff replacement services, professional and continued medical training services, pharmacy re-engineering services, and pharmaceutical training services.

Further Reading

Should You Invest $1,000 in KDA Group Right Now?

Before you consider KDA Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KDA Group wasn't on the list.

While KDA Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines